Skip to content
KStart free
AI InfrastructureDefenseQuantumAll studies →

TRDA US Equity

Entrada Therapeutics, Inc.Health Care · Pharmaceutical Preparations · CIK 1689375 · FY ends Dec 31
$7.27
-0.05 (-0.68%)
USD · as of 2026-08-18 · marketstack
7 8-K filings · 1 13D · 3 13G
DateEventWhat happened / filerSource
2026-08-1413G/ASchedule 13G amendment — ≥5% beneficial owner (passive) · by TCG Crossover GP I, LLCsec.gov ↗
2026-08-058-K 2.02Results of operations and financial condition (earnings)earnings history (EARN) →sec.gov ↗
2026-06-108-K 5.07Submission of matters to a vote of security holderssec.gov ↗
2026-06-108-K 5.02Departure/election of directors or officers; compensationsec.gov ↗
2026-05-188-K 7.01Regulation FD disclosuresec.gov ↗
2026-05-078-K 7.01Regulation FD disclosuresec.gov ↗
2026-05-078-K 2.02Results of operations and financial condition (earnings)earnings history (EARN) →sec.gov ↗
2026-02-268-K 2.02Results of operations and financial condition (earnings)earnings history (EARN) →sec.gov ↗
2026-01-088-K 8.01Other eventssec.gov ↗
2026-01-088-K 7.01Regulation FD disclosuresec.gov ↗
2026-01-088-K 2.02Results of operations and financial condition (earnings)earnings history (EARN) →sec.gov ↗
2025-11-2513GSchedule 13G filed — ≥5% beneficial owner (passive) · by TCG Crossover GP I, LLCsec.gov ↗
2025-11-1813D/ASchedule 13D amendment — ≥5% beneficial owner (active intent) · by 5AM Ventures V, L.P.sec.gov ↗
2025-11-1413G/ASchedule 13G amendment — ≥5% beneficial owner (passive) · by PRICE T ROWE ASSOCIATES INC /MD/sec.gov ↗
2025-11-068-K 2.02Results of operations and financial condition (earnings)earnings history (EARN) →sec.gov ↗
Source: SEC EDGAR (public domain) · history starts 2025-11-06

Every row is a filed document, checked against its EDGAR index.